Finance

Beta
Lists
300122:SHE
Chongqing Zhifei Biological Prdct Co Ltd
CNÂ¥12.44
-0.16%
(-0.020) 1D
Jun 5, 3:04:58 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300122...
Open
CNÂ¥12.58
High
CNÂ¥12.75
Low
CNÂ¥12.44
Mkt. cap
30.83B
Avg. vol.
20.69M
Volume
16.91M
52-wk high
CNÂ¥26.00
52-wk low
CNÂ¥12.36
EPS
-CNÂ¥6.19
Shares outstanding
2.39B
No. of employees
6K
Open
CNÂ¥12.58
High
CNÂ¥12.75
Low
CNÂ¥12.44
Mkt. cap
30.83B
Avg. vol.
20.69M
Volume
16.91M
52-wk high
CNÂ¥26.00
52-wk low
CNÂ¥12.36
EPS
-CNÂ¥6.19
Shares outstanding
2.39B
No. of employees
6K
News stories
From sources across the web
About Chongqing Zhifei Biological Prdct Co Ltd
CEO-
Employees6.29K
FoundedJul 20, 1995
Headquarters-
SectorBiotechnology
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
2.54B
2.71B
1.33B
2.15B
Cost of goods sold
1.99B
2.22B
16.06B
1.52B
Cost of revenue
1.99B
2.22B
16.06B
1.52B
Research and development expenses
191.70M
249.64M
263.60M
213.68M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
704.51M
684.90M
892.44M
384.00M
Operating expense
976.70M
1.02B
1.26B
963.02M
Total operating expenses
2.96B
3.23B
17.32B
2.49B
Operating income
-417.02M
-526.53M
-15.99B
-336.08M
Other non operating income
-3.16M
5.88M
-50.93M
-3.28M
EBT including unusual items
-451.15M
-729.02M
-15.98B
-444.91M
EBT excluding unusual items
-496.74M
-603.92M
-16.12B
-421.98M
Income tax expense
-159.19M
-106.64M
-2.45B
-51.20M
Effective tax rate
35.29%
14.63%
15.35%
11.51%
Other operating expenses
17.32M
18.37M
20.45M
11.78M
Net income
-291.95M
-609.32M
-13.52B
-388.32M
Net profit margin
-11.47%
-22.50%
-1,015.51%
-18.06%
Earnings per share
-
-
-
-
Interest and investment income
8.66M
5.38M
3.64M
3.26M
Interest expense
-80.22M
-93.64M
-87.14M
-85.87M
Net interest expenses
-71.57M
-88.26M
-83.50M
-82.61M
Depreciation and amortization charges
-
-
-
-
EBITDA
-295.77M
-433.46M
-15.87B
-211.40M
Gain or loss from assets sale
-5.82M
5.82M
-5.88M
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more